子宮内避妊器具の市場規模、シェア、成長分析、タイプ別、製品タイプ別、年齢層別、最終用途産業別、地域別 - 産業予測 2025～2032年

子宮内避妊器具の世界市場規模は2023年に44億米ドルと評価され、2024年の46億米ドルから2032年には66億米ドルに成長し、予測期間（2025-2032年）のCAGRは4.6%で成長する見通しです。

子宮内避妊器具（IUD）市場は、家族計画やリプロダクティブヘルスに対する意識の高まりにより、過去10年間で大幅な成長を遂げてきました。IUDは、その有効性とメンテナンスの必要性の低さで認知され、忙しい女性にとって魅力的な、日常的な注意を払うことなく長期間にわたる保護を提供します。市場参入企業や保健機関が認知度を高め、女性の社会進出が進み、ホルモン剤を使わない避妊オプションへの需要が高まっていることも、市場拡大をさらに後押ししています。技術の進歩や非ホルモン性IUDの導入は、ホルモン剤に代わる避妊法を求める女性に対応しています。しかし、IUDの安全性に関する文化的タブーや誤解、挿入の侵襲性の認識、サービスが行き届いていない地域でのコストなどが、より広い普及への課題となっています。このようなハードルにもかかわらず、IUD市場は特に新興経済圏で成長を続けています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• ケーススタディ
• 技術分析
• 顧客と購買基準の分析

子宮内避妊器具市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• ホルモン子宮内避妊器具
• 銅付加子宮内避妊器具

子宮内避妊器具市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• ミレーナ
• スカイラ
• パラガード
• エシュール
• レヴォセルト
• その他

子宮内避妊器具市場規模：年齢層別& CAGR（2025-2032）

• 市場概要
• 15～24歳
• 25～34歳
• 35～44歳
• 44歳以上

子宮内避妊器具市場規模：最終用途産業別& CAGR（2025-2032）

• 市場概要
• 病院
• 婦人科クリニック
• 地域医療センター
• その他

子宮内避妊器具市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Teva Pharmaceutical Industries Ltd.（Jerusalem）
• Bayer（Germany）
• EUROGINE（Spain）
• CooperSurgical Inc.（US）
• Pfizer Inc.（US）
• HLL Lifecare Limited（Thiruvananthapuram）
• OCON Medical Ltd.（Israel）
• Prosan International BV（Netherlands）
• Melbea Innovations（Hungary）
• Allergan, Merck & Co., Inc.（US）
• DKT International（US）
• Medisafe Distribution Inc.（Canada）
• Medicines360（US）
• Pregna International Limited（India）
• Egemen International（Turkey）

結論と提言

Global Intrauterine Contraceptive Devices Market size was valued at USD 4.4 billion in 2023 and is poised to grow from USD 4.6 billion in 2024 to USD 6.6 billion by 2032, growing at a CAGR of 4.6% during the forecast period (2025-2032).

The Intrauterine Contraceptive Devices (IUDs) market has seen substantial growth over the past decade, driven by heightened awareness of family planning and reproductive health. Recognized for their effectiveness and low maintenance needs, IUDs provide long-lasting protection without daily attention, appealing to busy women. Government initiatives and health organizations have amplified awareness, women's increased participation in the workforce, and a rising demand for hormone-free contraceptive options further bolster market expansion. Technological advancements and the introduction of non-hormonal IUDs cater to women seeking alternatives to hormonal methods. However, cultural taboos and misconceptions regarding IUD safety, alongside the perceived invasiveness of insertion and costs in underserved areas, pose challenges to wider adoption. Despite these hurdles, the IUD market continues to thrive, particularly in emerging economies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Contraceptive Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Contraceptive Devices Market Segments Analysis

The Global Intrauterine Contraceptive Devices Market is segmented by Type, Product Type, Age Group, End Use and region. Based on Type, the market is segmented into Hormonal Intrauterine Device and Copper Intrauterine Device. Based on Product Type, the market is segmented into Mirena, Skyla, Paragard, Essure, Levosert and Others. Based on Age Group, the market is segmented into 15-24 years, 25-34 years, 35-44 years and Above 44 years. Based on End Use, the market is segmented into Hospitals, Gynecology Clinics, Community Health Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrauterine Contraceptive Devices Market

The global market for intrauterine contraceptive devices (IUDs) is significantly driven by the increasing adoption of long-acting reversible contraceptives (LARCs). Women are gravitating towards methods that not only provide high effectiveness and low maintenance but also offer long-term pregnancy prevention, with IUDs boasting over 99% effectiveness and lasting 3 to 10 years depending on the type. This makes them a favorable alternative to daily or short-term contraceptive methods. Moreover, the advocacy of healthcare professionals, who often recommend LARCs as a primary contraceptive choice, further boosts IUD usage. Enhanced awareness campaigns highlight the convenience and reliability of these options, increasing their acceptance across diverse demographics and regions.

Restraints in the Global Intrauterine Contraceptive Devices Market

Despite the medical benefits of intrauterine contraceptive devices (IUDs), their adoption is often hindered by cultural and social barriers in many regions globally, including Asia, Africa, and the Middle East. Misconceptions surrounding IUD safety, potential fertility impacts, and procedural discomfort continue to prevail. Additionally, discussions about contraception are frequently stigmatized, leaving women with limited access to effective birth control options like IUDs. Fears about severe side effects and religious objections further inhibit market penetration. To improve awareness and acceptance of IUDs among hesitant groups, targeted educational and community outreach campaigns are essential to dispel myths and promote informed choices.

Market Trends of the Global Intrauterine Contraceptive Devices Market

The Global Intrauterine Contraceptive Devices (IUDs) market is experiencing a significant shift towards non-hormonal contraceptive options, driven by growing consumer preference for hormone-free solutions. As awareness of potential side effects associated with hormonal birth control rises, more women are gravitating toward devices like the Copper IUD, which offer long-term efficacy without altering hormonal balance. This trend is particularly pronounced in health-conscious populations seeking non-invasive, reliable alternatives. Consequently, manufacturers are adapting by innovating designs and enhancing comfort in non-hormonal IUDs, positioning these products competitively within the global market landscape and catering to the increasing demand for safer contraceptive choices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Customer & Buying Criteria Analysis

Global Intrauterine Contraceptive Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Hormonal Intrauterine Device
• Copper Intrauterine Device

Global Intrauterine Contraceptive Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Mirena
• Skyla
• Paragard
• Essure
• Levosert
• Others

Global Intrauterine Contraceptive Devices Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• 15-24 years
• 25-34 years
• 35-44 years
• Above 44 years

Global Intrauterine Contraceptive Devices Market Size by End Use Industry & CAGR (2025-2032)

• Market Overview
• Hospitals
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Contraceptive Devices Market Size & CAGR (2025-2032)

• North America (Type, Product Type, Age Group, End Use Industry)
  • US
  • Canada
• Europe (Type, Product Type, Age Group, End Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product Type, Age Group, End Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product Type, Age Group, End Use Industry)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product Type, Age Group, End Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceutical Industries Ltd. (Jerusalem)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited (Thiruvananthapuram)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea Innovations (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan, Merck & Co., Inc. (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisafe Distribution Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360 (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Egemen International (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations